chrisvoncsefalvay/vaers-outcomes huggingface dataset:
moderate pain lasting 1 day, becoming mild pain for 1 day redness and swelling on arm lasting 4+ days (still there but fading, 3" x 4") tiredness lasting 3 days muscle pain (entire body), lasting  1 1/2 days headache (right side of head), lasting 1 day shivering, lasting  1 1/2 days fever, lasting  1 1/2 days stomach pain, lasting 1 day nausea, lasting   1/2 days insomnia, lasting  2 days sweating, lasting  3 days dehydration, 7 pound weight loss in 24 hrs, severe one day, required 2 days to rehydrate regained 4 pounds
Pt devel cellulitis @ the inject site two-to-three days p/receiving Td;
Parents brought patient to our clinic today for a physical. State that after her shots last July she developed intractable crying and fever. Was in the ER all night. Father states that the doctor said the fever and crying was related to the shots. No other vaccines given since that time. Family not certain if a VAERS report was filed. This is all the information that I have! Today I gave patient an MMR-the father refused to repeat any of the previous vaccines and insists that we only give one vaccine at a time!
Information has been received from a healthcare worker refers to an unspecified number of patients of unknown age and gender who were administered an unspecified number of doses of PEDVAXHIB (lot#, expiration date, dose, strength and route not reported) on unspecified date since 26-OCT-2014 which had been improperly stored. No adverse effects reported. It was unspecified if the patients sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Pt complained of low grade fever starting the day after administration (9/8/10) and lasting at least through 9/17/10.
Doses administered after more than 1 temperature excursion; Doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021 at 10:22 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2022 at 10:27 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 37.81. Concomitant products were not reported. On 14-Feb-2021, Excursion time was 9AM,10AM,11AM,2PM,3PM temperature was 32,32,32,35,35 total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021. On 21-Mar-2021, Excursion time was 9AM,10AM,11AM temperature was 34,32,34total doses given for the day was 94, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 16-Mar-2021, vial was moved to clinic on 21-Mar-2021. 10 vials were sent to clinic. Vaccine BUD date was 15-Arp-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Pt developed wheezing and increased temperature to 102F after 2nd DTAP, IPV and Comvax. Pt had hives after the 1st DTAP, IPV and Comvax.
Narrative:  Patient reported feeling flu like symptoms following administration of second pfizer covid vaccine. Patient went to urgent care and was contacted for follow up approximately 3 days later when she reported feeling much better.
Narrative:  78yo male, patient died on 8/30/2022. Pt had received COVID VACCINE EUA (J&J) on 8/13/2021. Pt presented to Emergency room on 8/30/22. Information below: Emergency Notification Intake Date Presenting to the Facility: Aug 30,2022 Method of Contact: self presented Notified from worklist Notification ID: Referral #: Community Hospital Name: Hospital: Address: City: State: Zip Code: Phone: Community Facility Point of Contact: Name: Emergency room Phone: Chief complaint: Shortness of Breath Primary Diagnosis: - No other information available regarding pt's death at this facility.
I had my first Shingrix 9 months ago can I still get my second shot; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date, 9 months prior to reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive second dose, which led to incomplete course of vaccination. The reporter enquired if he/ she could still get the second shot or if he/ she needed to start over.
Immunization given on 09/12/2002. Appt at 11:40 am, spoke with SSD, Conversation translated, Immunization given, DTaP to RAT, Varicella LLT, SSD reported right leg swollen, Site hot red, pain to touch.
fever; chills; fatigue ("we just wanted to go to bed"); no appetitie; felt really sick after the vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 21-Jan-2021.    This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue ("we just wanted to go to bed")), DECREASED APPETITE (no appetitie) and ILLNESS (felt really sick after the vaccine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue ("we just wanted to go to bed")), DECREASED APPETITE (no appetitie) and ILLNESS (felt really sick after the vaccine). At the time of the report, PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue ("we just wanted to go to bed")), DECREASED APPETITE (no appetitie) and ILLNESS (felt really sick after the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were provided No treatment were provided
Sore upper arm for first 24 hrs and  dull headache starting 1/13/21, 2pm) ; Took acetaminophen Sudden onset severe chills/shivering, nausea, worse headache approx 24 hrs later (1/14/21, noon). Chills and nausea gone by 2am 1/15/21. Very sore arm persisting until 1/18/21, mid-day.
pt recv vax 13NOV96 & pt devel a rash on chest & neck;pt was not seen by MD;
Patient said he was nervous and after his first COVID dose he fainted in the chair. Last time he ate or drank anything was at 3am on 12/22/2021.  Ambulance called and patient refused to go to the hospital.
Information has been received from a 79-year-old female with no reported medical history or allergies, who on 27-JUN-2007, was vaccinated with ZOSTAVAX (Merck).  Concomitant therapy included HCTZ/triamterene, ACTONEL and LEVOXYL.  On 02-JUL-2007, the patient developed blisters on the left side of her upper torso which stretched from her chest area to under her left arm and on the left side of her back.  The patient went to her physician and she was diagnosed with shingles.  The blisters have occasionally caused her some stabbing pains.  The patient reported that on one occasion, the blisters began to bleed when she made a sudden arm movement. As of 17-AUG-2007, the blisters had dried up and she had some scarring.  The patient stated that the dried up blisters felt like a bad sunburn and the stabbing pains have diminished somewhat.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 9/24/2007. Follow-up information has been received from a physician's assistant concerning a 79-year-old retired female with hypertension, osteoarthritis, hypothyroidism and osteopenia who was vaccinated intramuscularly in the left arm on the morning of 27-Jun-2007 with a first fose of ZOSTAVAX (Merck). There was no illness at the time of vaccination. Concomitant medications included: hydrochlorotiazide (+) triamterene and LEVOXYL, ACTONEL and prediem-otc". On 02-Jul-2007 (also reported as 06-JUL-2007) she developed a vesicular eruption in a dermatomal pattern under the left axillia, across left chest and left upper back that was diagnosed as shingles. It was reported that the patient was seen for office visits on 11-JUL-2007 and 15-AUG-2007. The patient experienced burning, pain, and tenderness. She was treated with VALTREX. 1 gram, TID x 7 days. On 03-Aug-2007 her condition was not improving and she was diagnosed with postherpetic neuralgia and was prescribed NEURONTIN 300 miligrams, PO before bed. On 15-Aug-2007, the NEURONTIN was increased to 300 miligrams, PO, TID for postherpetic neuralgia. No laboratory or diagnostic tests were performed. At the time of the report the patient had not recovered. additional information is not expected.
The pt experienced a severe local reaction where the left thigh and the right thigh had discoloration.
Vaccine overdose; Office manager calling to report that a dose of VAXELIS and an unspecified hepatitis B vaccine were accidently concomitantly administered to a 2 month old patient.; This spontaneous safety report with reference number 02305666 (02305660) was received by the partner on 20-Dec-2022 and forwarded to Agency on 20-Dec-2022 from a Nurse Practitioner.  Due to the nature of the events, the causality between Wrong product administered, and Overdose and Vaxelis was not applicable.  Further information is expected
Everything went fine but my face got numb 5 minutes after injection and continues today more than 24 hours later.
Initial report received from a physician on 26 January 2007. A patient (age and gender not reported) experienced a black dot after receiving Fluzone (lot number unknown, site, route and date of administration not reported). The patient's black dot persisted over a month. Additional information was not provided.
Fever, soreness at injection site Narrative: Per nursing report: "C/o took 2nd Moderna vaccine yesterday about 1:30 and c/o feeling cold, breathing hard and temp of 100l.2. 02 sat 97% on room air. Temp down to 99.2. Also c/o soreness at site of injection to right arm."
Rash across the abdomen, then the following day redness down the left arm, both of which continued to get worse.  Fever around 101, muscle soreness. Treated with oral ibuprofen and oral diphenhydramine. Fever and muscle cleared in 3 days.  Redness still there today.
pt recvd vax & devel rash & fever; rash raised, red spread from abdo to back; rash on legs & arms, 1 emesis; MD felt rash could be viral or rxn to vax; purpura noted on legs
severe flu like symptoms for 2 weeks and scabbing at injection sites(5 inch radius). if remove would ooze and rescab. no tingling or neuropathy. Had diarrhea, fever, nausea,malaise, no vomiting,
8-6-20 - Midnight - Pt reports started getting a strange feeling in Left arm that he received shots in. Got slightly worse - then leveled in intensity. Woke up - Left arm continued with discomfort - slight tingling in tongue - that resolved. 8-7-20 9AM (L) Arm discomfort reports on how he is holding his arm. Reports after the shots in left arm - arm was sore x 1wk. Day after (L) arm felt strange sensation. Had worked out with weights - heavy workout - Did arm curls with left arm - vigorously. Has taken nothing for discomfort. Referred to Medical Provider if S/S worsen or do not  improve for follow up.
oct 1 Left arm hurting. oct 2 - Bruise developed 3 in. down from injection site oct 3 - Pins & needle sensation developed  in both arms & legs.  oct 7 Burning sensation started around bruise area. oct 8 - upper back & left shoulder area  aching off & on Symptoms are still bothering me as of 11-1-2020 Left arm not hurting as much. A lot of burning sensation & pins & needles however in both arms & left shoulder area.  Pins & needles in legs subsided.
FEVER; CHILLS; UPSET STOMACH; PAIN; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, chills, upset stomach and pain. The patient was treated with ibuprofen and paracetamol (Acetaminophen). On an unknown date, the outcome of the fever, chills, upset stomach and pain were unknown.   It was unknown if the reporter considered the fever, chills, upset stomach and pain to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received the 2nd dose of Shingrix for shingles and experienced symptoms of chills, fever and upset stomach.  The patient asked recommendation for a pain reliever as he/she got Ibuprofen and Acetaminophen. The follow-up would not possible as no contact details were available.
COUGH; FEVER; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 25-JUN-2021, the subject experienced cough. On 25-JUN-2021, the subject experienced fever. On 25-JUN-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cough, fever and headache was not reported. This report was non-serious.
My daughter got her 4 months old vaccine shots on February 21st 20/20 we came home and stayed home. the next day Saturday we slept in late I didn't notice anything strange about her it was my day off. we spent the whole day playing and loving each other and we went to bed early Sunday morning at about 3 A.m. of course she had naps throughout the day but when I finally went to sleep with her it was 3 in the morning. During the night after bed I noticed that her nose is running .I wiped her nose I went back to sleep and when I woke back up I noticed her nose was running a lot I thought she had a bad cold it had just snowed a few days ago even though she didn't go in the snow I just thought maybe she had a running nose . but I noticed her chest wasn't moving when I went to pick her up a whole bunch of fluid just rushed out of her face. I ran to my roommate we got into the car went to the hospital and they could not resuscitate my baby. nothing changed in her routine except for all those vaccine shots she got on that Friday the day before.
High blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003821A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure increased, Lactose intolerance, Gluten intolerance, Allergy to metals, Allergy to antibiotic and Allergy to antibiotic. Concomitant products included IRBESARTAN and VERAPAMIL for an unknown indication.   On 23-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced HYPERTENSION (High blood pressure). The patient was treated with CLONIDINE HCL at a dose of 1 mg. On 24-Mar-2021, HYPERTENSION (High blood pressure) had resolved.            This case was linked to MOD-2021-026426, MOD-2021-026426 (Patient Link).
Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Joint Pain-Medium
Patient developed flesh colored papules on the bilateral hands, petechiae on the bilateral hands, and a burning sensation to the hands and feet.
Burning nerve pain (occipital nerve), migraine, stiff neck, stiff arm (spread all the way to halfway down forearm), stiff trapezius muscle. Symptoms started out relatively mild (0840 10/30/15) and then became intense (0700 10/31/15). Got even worse through 10/31/15 until received treatment. As of 11/01/15, symptoms present in a moderate state but managed with Methocarbamol, Tylenol with codeine, and Prednisone.
Swollen lymph nodes; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (Patient) reported a 42-years-old female patient started to receive the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1686  ) , via an unspecified route of administration on 19Jan2021 at SINGLE DOSE right Arm for covid-19 immunisation.  The first dose bnt162b2 was received on 28Dec2020 for covid-19 immunisation. Medical history included severe allergies, hypothyroidism.  There were no concomitant medications.  The patient experienced swollen lymph nodes on 20Jan2021. The patient has done no treatment for the swollen lymph node, not even applying heat. The outcome of event was unknown.
Patient describes generalized (whole body) itching after receiving vaccinations. This is patient's 2nd Shingrix shot, and he did not have such a reaction to the first.  He is still feeling the itching since 12/5/22, but has noticed some improvement.  He notes that during this time he has been to a hospital for a hip replacement, unrelated. He went to a doctor who provided him with an antibiotic & steroid and was told this may help with the itching.
A report was received from an health care professional on 10/09/2003 concerning a 42 year old female vaccinee who experienced redness, warmth, itching and developed a quarter-sized knot at the injection site on 10/09/03 after receiving Fluvirin vaccine on 10/09/2003.  The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update1, 11/4/2003: Further information received from a health care professional on 11/4/2003 indicated that the vaccinee received Fluvirin vaccine on 10/08/2003.  The event duration was 4 days, resolving on 11/13/2003. No follow up pending, all information received.
None. Patient said she got subcutaneous injection instead of an intramuscular injection. Pharmacist thinks otherwise.
Large hives on extremities followed by itching sensation. Mainly in shoulder, elbow, wrist, knees went away in a.m. reappeared at p.m. the next evening that was present on torso and extremities, itching kept him awake. We put itching cream on to make more comfortable. Most gone by a.m. Reappeared on injection shoulder encompassing whole shoulder, gone within an hour.
Vaccinator gave a Moderna Vaccine to patient past the vaccines beyond use date (BUD). Patient was observed for a period of 15 min after injection with no adverse reaction. Vaccinator was re educated on checking all expiration dates and BUD of Vaccines before admnistering.
vaccine administered at 12:18pm, client ambulated to observation area. @12:23pm client complained of nausea and vomiting, redness noted to chest and neck. Client given 20ml Benadryl PO*1 @ 12:27pm. Client moved from chair to floor @ 12:34pm. Client complained of tightness in chest, lungs clear no wheezing noted. 0.5mg Epi administered RT @ 12:33pm. 911 called at 12:32pm, arrived @ 12:42pm. Client alert and oriented to person, place and time. Redness centralized to chest and neck, not noted on abdominal area or arms. Client transported to local hospital.
Injection site soreness; headache; body aches; This is a spontaneous report from a non-contactable consumer, the patient. This 44 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) , single dose, dose 2 via unknown route of administration in the left arm on 16Feb2021 at 13:30 (at the age of 44 years-old) for COVID-19 vaccination. Medical history was not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) on 26Jan2021 at 2: 15 PM. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. The patient did not receive any concomitant medications. The patient was not on any medications in two weeks. On 16Feb2021 at 16:00, the patient experienced injection site soreness, headache and body aches. No treatment was received for injection site soreness, headache and body aches. The clinical outcome of injection site soreness, headache and body aches was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow up attempts are possible. No further information is expected.
Sharp headaches, Pain level 2-3 most all time with sporadic 20 minute pains of 8-10+ (pain scale of 1-10).
Day 1: Nausea, headache 8 hrs. post injection. Day 2:  Headache, fatigue, fever.  Temp @ 9:30 am =100.1; Temp @ 4:15 pm=101.6  Ibuprofen 200mg X2 P.O. @4:20 pm Treatment evaluation ongoing
pt recv vax;devel angioedema around mouth;seen in er;sx resolving;MD to perform more tests to determine cause;
Fever, headache, fatigue, sneezing, runny nose for a day and then swelling under one eye the next day and still occurring but all other symptoms gone after 24 hours.
pt recvd unk # of doses of Engerix-B & exp arthralgia; No further details are available;